Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 3476 | 1056 | 34.6 | 55% |
Classes in level above (level 3) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 443 | 24079 | ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//VITAMIN A |
Classes in level below (level 1) |
| ID, lev. below | Publications | Label for level below |
|---|---|---|
| 13270 | 784 | EMBRYONAL CARCINOMA//TERATOCARCINOMA//HNT |
| 25968 | 220 | JOINT EFFUSIONS//JUMPING HORSE//MED BLOOD TRANSFUS UNIT |
| 35110 | 52 | HYG PUBL HLTH MED//MESOGENESIS//TOKYO HLTH ADM |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | EMBRYONAL CARCINOMA | Author keyword | 7 | 15% | 4% | 41 |
| 2 | TERATOCARCINOMA | Author keyword | 5 | 19% | 2% | 24 |
| 3 | HNT | Author keyword | 5 | 63% | 0% | 5 |
| 4 | HNT NEURONS | Author keyword | 4 | 50% | 1% | 6 |
| 5 | NT2N | Author keyword | 4 | 56% | 0% | 5 |
| 6 | NTERA 2 | Author keyword | 3 | 43% | 1% | 6 |
| 7 | NT2A | Author keyword | 3 | 100% | 0% | 3 |
| 8 | NTERA2 | Author keyword | 3 | 33% | 1% | 7 |
| 9 | HNT NEURON | Author keyword | 3 | 50% | 0% | 4 |
| 10 | NT2 N NEURONS | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | EMBRYONAL CARCINOMA | 7 | 15% | 4% | 41 | Search EMBRYONAL+CARCINOMA | Search EMBRYONAL+CARCINOMA |
| 2 | TERATOCARCINOMA | 5 | 19% | 2% | 24 | Search TERATOCARCINOMA | Search TERATOCARCINOMA |
| 3 | HNT | 5 | 63% | 0% | 5 | Search HNT | Search HNT |
| 4 | HNT NEURONS | 4 | 50% | 1% | 6 | Search HNT+NEURONS | Search HNT+NEURONS |
| 5 | NT2N | 4 | 56% | 0% | 5 | Search NT2N | Search NT2N |
| 6 | NTERA 2 | 3 | 43% | 1% | 6 | Search NTERA+2 | Search NTERA+2 |
| 7 | NT2A | 3 | 100% | 0% | 3 | Search NT2A | Search NT2A |
| 8 | NTERA2 | 3 | 33% | 1% | 7 | Search NTERA2 | Search NTERA2 |
| 9 | HNT NEURON | 3 | 50% | 0% | 4 | Search HNT+NEURON | Search HNT+NEURON |
| 10 | NT2 N NEURONS | 2 | 67% | 0% | 2 | Search NT2+N+NEURONS | Search NT2+N+NEURONS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NTERA 2 CELLS | 17 | 34% | 4% | 41 |
| 2 | NTERA 2 | 14 | 100% | 1% | 7 |
| 3 | DIFFERENTIATED NEURONS | 10 | 73% | 1% | 8 |
| 4 | NT2N | 9 | 83% | 0% | 5 |
| 5 | TERA 2 | 8 | 75% | 1% | 6 |
| 6 | HUMAN NT 2 NEURONS | 6 | 80% | 0% | 4 |
| 7 | HNT NEURONS | 5 | 29% | 1% | 15 |
| 8 | AGGREGATION METHOD | 4 | 56% | 0% | 5 |
| 9 | ISCHEMIC RATS | 3 | 30% | 1% | 8 |
| 10 | LINE NTERA 2 | 2 | 67% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| FROM EMBRYONAL CARCINOMA-CELLS TO NEURONS - THE P19 PATHWAY | 1994 | 198 | 37 | 43% |
| Tumorigenicity issues of embryonic carcinoma-derived stem cells: Relevance to surgical trials using NT2 and hNT neural cells | 2005 | 38 | 103 | 44% |
| Timeline - From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research | 2006 | 129 | 76 | 13% |
| Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke | 2008 | 27 | 109 | 21% |
| MAINTENANCE AND USE OF F9 TERATOCARCINOMA CELLS | 1990 | 31 | 8 | 63% |
| Human model neurons in studies of brain cell damage and neural repair | 2007 | 4 | 135 | 36% |
| TUMORS AS CARICATURES OF THE PROCESS OF TISSUE RENEWAL - PROSPECTS FOR THERAPY BY DIRECTING DIFFERENTIATION | 1988 | 246 | 63 | 19% |
| HUMAN TERATOCARCINOMA STEM-CELLS - GLYCOLIPID ANTIGEN EXPRESSION AND MODULATION DURING DIFFERENTIATION | 1987 | 20 | 36 | 67% |
| HUMAN TERATOCARCINOMAS | 1988 | 98 | 105 | 38% |
| Neurotransmitter receptor expression and activity during neuronal differentiation of embryonal carcinoma and stem cells: from basic research towards clinical applications | 2006 | 28 | 109 | 14% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AGING BRAIN REPAIR | 1 | 16% | 0.8% | 8 |
| 2 | PSYCHIAT PHARMACOL PSYCHOL | 1 | 100% | 0.2% | 2 |
| 3 | 36TH ST SPRUCE | 1 | 50% | 0.1% | 1 |
| 4 | COMPARAT PHYSIOL MUZEUM KRT 4A | 1 | 50% | 0.1% | 1 |
| 5 | H LEE MOFFIT CANC HOSP | 1 | 50% | 0.1% | 1 |
| 6 | HYG PUBL HLTH MED | 1 | 50% | 0.1% | 1 |
| 7 | MED BLOOD TRANSFUS UNIT | 1 | 50% | 0.1% | 1 |
| 8 | NEUROGLYCOBIOLKITA KU | 1 | 50% | 0.1% | 1 |
| 9 | REPROD STEM CELL | 1 | 50% | 0.1% | 1 |
| 10 | SEROBACTERIOL | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 2) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000016373 | METHYLSULFONYLMETHANE//LEUKEMIA CELL DIFFERENTIATION//N ACETYL S N METHYLCARBAMOYLCYSTEINE |
| 2 | 0.0000016221 | VITAMIN A//RETINOIC ACID//RETINOIDS |
| 3 | 0.0000015824 | TESTICULAR CANCER//TESTICULAR NEOPLASMS//SEMINOMA |
| 4 | 0.0000014972 | XIST//X CHROMOSOME INACTIVATION//TSIX |
| 5 | 0.0000014747 | CELL & TISSUE ENGINEERING//MESENCHYMAL STEM CELLS//PLURIPOTENCY |
| 6 | 0.0000010031 | DLX4//DLX3//CANC DEV BIOL MATERNAL FETAL BIOL |
| 7 | 0.0000009778 | LOX 1//OXIDIZED LDL//SCAVENGER RECEPTOR |
| 8 | 0.0000007727 | LAMININ//FIBRONECTIN//INVASION & METASTASIS |
| 9 | 0.0000007402 | FIBROBLAST GROWTH FACTOR//KERATINOCYTE GROWTH FACTOR//SPROUTY |
| 10 | 0.0000007168 | NEUROCHEM NEUROBIOL//GLIA MATURATION FACTOR//GLIA MATURATION FACTOR GMF |